Sonoma Pharmaceuticals, Inc. (SNOA)

Sonoma Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	3.13	3.13	3.82	7.4	4.22	3.69
Cash & Cash Equivalents	3.13	3.13	3.82	7.4	4.22	3.69
Cash Growth	-18.12%	-18.12%	-48.35%	75.26%	14.33%	0.05%
Receivables	2.9	2.9	2.57	2.41	2.81	3.97
Inventory	2.72	2.72	2.86	2.66	2.53	2.18
Other Current Assets	3.8	3.8	4.55	3.96	3.43	2.44
Total Current Assets	12.55	12.55	13.8	16.43	12.98	12.28
Property, Plant & Equipment	0.65	0.65	0.91	0.88	1.13	0.72
Other Long-Term Assets	1.54	1.54	1.53	1.54	0.88	1.55
Total Long-Term Assets	2.19	2.19	2.43	2.42	2	2.28
Total Assets	14.74	14.74	16.23	18.85	14.99	14.56
Accounts Payable	0.61	0.61	0.84	1.64	1.77	2.07
Deferred Revenue	0.57	0.57	0.3	1.46	0.55	0.52
Current Debt	0.52	0.52	0.69	1.06	0.84	0.62
Other Current Liabilities	2.03	2.03	1.89	1.66	0.93	1.53
Total Current Liabilities	3.72	3.72	3.72	5.82	4.08	4.73
Long-Term Debt	0.09	0.09	0.16	0.31	1.84	0.24
Other Long-Term Liabilities	4.8	4.8	4.38	4.02	3.71	3.97
Total Long-Term Liabilities	4.88	4.88	4.54	4.33	5.55	4.21
Total Liabilities	8.6	8.6	8.25	10.15	9.62	8.94
Total Debt	0.61	0.61	0.85	1.37	2.68	0.85
Debt Growth	-28.39%	-28.39%	-37.89%	-48.90%	214.71%	78.95%
Retained Earnings	-194.35	-194.35	-189.51	-184.36	-179.28	-175.33
Comprehensive Income	-2.72	-2.72	-3.42	-4.31	-4.58	-5.61
Shareholders' Equity	6.14	6.14	7.98	8.7	5.36	5.62
Net Cash / Debt	2.52	2.52	2.97	6.03	1.55	2.84
Net Cash / Debt Growth	-15.18%	-15.18%	-50.72%	290.23%	-45.62%	-11.61%
Net Cash Per Share	0.28	0.28	0.88	2.27	0.77	1.92
Working Capital	8.83	8.83	10.08	10.61	8.91	7.55
Book Value Per Share	0.68	0.68	2.35	3.28	2.69	3.81

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).